Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) Stock Ticker

NYSE: ANVS · Healthcare · Biotechnology
$1.31-1.50%
USD · as of 2026-09-28 · market cap $55.7M
Open ANVS in TickrDownload for iPhone

ANVS right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±15.1%
Options expect by Oct 29±31.3%
Priced in for Nov 11 earnings±37.5%
IV rank (30-day)23% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ANVS picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ANVS
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Annovis Bio, Inc.

Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.

ANVS stock facts

Ticker symbolANVS
ExchangeNew York Stock Exchange
SectorHealthcare
IndustryBiotechnology
Market cap$55.7M
CEOMaria L. Maccecchini
Employees7
HeadquartersMalvern, PA, US
IPO date2020-01-29
Websitewww.annovisbio.com

What you can see for ANVS on Tickr

Live ANVS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ANVS report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Annovis Bio, Inc.?

The ticker symbol for Annovis Bio, Inc. is ANVS, listed on the New York Stock Exchange.

What is ANVS?

Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals…

HomeExploreMarketLists
All pages